![Stacey Liekweg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Stacey Liekweg has held positions as President & Director at Immunovalent Therapeutics, Inc. and Chief Operating Officer at Caelivascular, Inc.
Actieve functies van Stacey Liekweg
Bedrijven | Functie | Begin |
---|---|---|
Immunovalent Therapeutics, Inc.
![]() Immunovalent Therapeutics, Inc. BiotechnologyHealth Technology Immunovalent Therapeutics, Inc. is a medicine company harnessing microfluidic technology for the treatment of cancer immunotherapy. The company is headquartered in St. Louis, MO. | President | - |
Caelivascular, Inc.
![]() Caelivascular, Inc. Medical SpecialtiesHealth Technology CaeliVascular, Inc. is a medical company that specializes in developing innovative catheters for vascular surgery. The company is based in St. Louis, MO. The company's focus is on transforming the treatment of deep vein thrombosis and pulmonary embolism. The CEO of the company is John Hardin. | Operationeel Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Immunovalent Therapeutics, Inc.
![]() Immunovalent Therapeutics, Inc. BiotechnologyHealth Technology Immunovalent Therapeutics, Inc. is a medicine company harnessing microfluidic technology for the treatment of cancer immunotherapy. The company is headquartered in St. Louis, MO. | Health Technology |
Caelivascular, Inc.
![]() Caelivascular, Inc. Medical SpecialtiesHealth Technology CaeliVascular, Inc. is a medical company that specializes in developing innovative catheters for vascular surgery. The company is based in St. Louis, MO. The company's focus is on transforming the treatment of deep vein thrombosis and pulmonary embolism. The CEO of the company is John Hardin. | Health Technology |